In the current study, we demonstrate that PM2.5 upregulates IL4I1, which controls AhR/CYP1B1 signaling, leading to barrier dysfunction, EMT and CRS pathogenesis. The gene discussed is IL4I1; the disease is congenital rubella syndrome.